Evoke Pharma Inc (EVOK)
4.366
+0.11
(+2.48%)
USD |
NASDAQ |
Nov 14, 16:00
4.70
+0.33
(+7.65%)
After-Hours: 05:41
Evoke Pharma Cash and Short Term Investments (Quarterly): 11.34M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 11.34M |
| June 30, 2024 | 9.178M |
| March 31, 2024 | 9.703M |
| December 31, 2023 | 4.739M |
| September 30, 2023 | 5.965M |
| June 30, 2023 | 7.006M |
| March 31, 2023 | 8.213M |
| December 31, 2022 | 9.844M |
| September 30, 2022 | 12.35M |
| June 30, 2022 | 13.45M |
| March 31, 2022 | 7.701M |
| December 31, 2021 | 9.145M |
| September 30, 2021 | 11.14M |
| June 30, 2021 | 16.72M |
| March 31, 2021 | 18.19M |
| December 31, 2020 | 8.069M |
| September 30, 2020 | 6.281M |
| June 30, 2020 | 7.990M |
| March 31, 2020 | 4.133M |
| December 31, 2019 | 5.664M |
| September 30, 2019 | 6.505M |
| June 30, 2019 | 7.440M |
| March 31, 2019 | 4.029M |
| December 31, 2018 | 5.319M |
| Date | Value |
|---|---|
| September 30, 2018 | 6.568M |
| June 30, 2018 | 6.531M |
| March 31, 2018 | 5.406M |
| December 31, 2017 | 7.679M |
| September 30, 2017 | 10.41M |
| June 30, 2017 | 12.56M |
| March 31, 2017 | 14.66M |
| December 31, 2016 | 9.007M |
| September 30, 2016 | 10.38M |
| June 30, 2016 | 4.129M |
| March 31, 2016 | 6.100M |
| December 31, 2015 | 8.691M |
| September 30, 2015 | 10.74M |
| June 30, 2015 | 9.883M |
| March 31, 2015 | 11.69M |
| December 31, 2014 | 14.16M |
| September 30, 2014 | 12.18M |
| June 30, 2014 | 16.05M |
| March 31, 2014 | 21.84M |
| December 31, 2013 | 24.20M |
| September 30, 2013 | 23.74M |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 0.116M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
4.133M
Minimum
Mar 2020
18.19M
Maximum
Mar 2021
9.341M
Average
8.679M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Repligen Corp | 809.15M |
| Eli Lilly and Co | 3.518B |
| MEI Pharma Inc | 38.34M |
| Revance Therapeutics Inc | 184.08M |
| NovaBay Pharmaceuticals Inc | 0.776M |